Irradiated Cannabis: Radioactivity, Terpenes, and Safety
#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
The Food and Drug Administration (FDA) has issued guidelines for irradiated cannabis, a process that maintains THC and CBD stability but may affect terpene composition. Clinicians should be aware of potential variations in terpene profiles when prescribing or advising patients on the use of irradiated cannabis products.
🔬 In the realm of cannabis research, a recent focus has been irradiated cannabis, as outlined in the FDA’s guidance. While studies suggest that gamma-treated cannabis maintains stability in THC and CBD content, the impact on terpenes remains variable. This complexity underscores the need for continued investigation into the long-term effects of irradiation on both cannabinoid and terpene profiles. In clinical practice, healthcare providers should be aware that while irradiated cannabis may offer potential benefits in preserving potency, further research is necessary to fully understand its impact on therapeutic efficacy and safety profile, particularly regarding changes in terpene composition.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: